514 related articles for article (PubMed ID: 12034052)
1. Thyroid disease and lipids.
Duntas LH
Thyroid; 2002 Apr; 12(4):287-93. PubMed ID: 12034052
[TBL] [Abstract][Full Text] [Related]
2. Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice.
Berti JA; Amaral ME; Boschero AC; Nunes VS; Harada LM; Castilho LN; Oliveira HC
Metabolism; 2001 May; 50(5):530-6. PubMed ID: 11319713
[TBL] [Abstract][Full Text] [Related]
3. Relations between thyroid function, hepatic and lipoprotein lipase activities, and plasma lipoprotein concentrations.
Valdemarsson S; Hansson P; Hedner P; Nilsson-Ehle P
Acta Endocrinol (Copenh); 1983 Sep; 104(1):50-6. PubMed ID: 6624364
[TBL] [Abstract][Full Text] [Related]
4. Effect of thyroid dysfunction on high-density lipoprotein subfraction metabolism: roles of hepatic lipase and cholesteryl ester transfer protein.
Tan KC; Shiu SW; Kung AW
J Clin Endocrinol Metab; 1998 Aug; 83(8):2921-4. PubMed ID: 9709970
[TBL] [Abstract][Full Text] [Related]
5. Effects of Short-Term Hypothyroidism on the Lipid Transfer to High-Density Lipoprotein and Other Parameters Related to Lipoprotein Metabolism in Patients Submitted to Thyroidectomy for Thyroid Cancer.
Sigal GA; Tavoni TM; Silva BMO; Kalil Filho R; Brandão LG; Maranhão RC
Thyroid; 2019 Jan; 29(1):53-58. PubMed ID: 30412041
[TBL] [Abstract][Full Text] [Related]
6. The effect of thyroid disorders on lipid levels and metabolism.
Duntas LH; Brenta G
Med Clin North Am; 2012 Mar; 96(2):269-81. PubMed ID: 22443975
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein alterations, hepatic lipase activity, and insulin sensitivity in subclinical hypothyroidism: response to L-T(4) treatment.
Brenta G; Berg G; Arias P; Zago V; Schnitman M; Muzzio ML; Sinay I; Schreier L
Thyroid; 2007 May; 17(5):453-60. PubMed ID: 17542675
[TBL] [Abstract][Full Text] [Related]
8. [Thyroid diseases, dyslipidemia and cardiovascular risk].
Jiskra J; Límanová Z; Antosová M
Vnitr Lek; 2007 Apr; 53(4):382-5. PubMed ID: 17578170
[TBL] [Abstract][Full Text] [Related]
9. Effect of levo-thyroxine replacement on non-high-density lipoprotein cholesterol in hypothyroid patients.
Ito M; Arishima T; Kudo T; Nishihara E; Ohye H; Kubota S; Fukata S; Amino N; Kuma K; Sasaki I; Hiraiwa T; Hanafusa T; Takamatsu J; Miyauchi A
J Clin Endocrinol Metab; 2007 Feb; 92(2):608-11. PubMed ID: 17148561
[TBL] [Abstract][Full Text] [Related]
10. Plasma lipoproteins and regulation of hepatic metabolism of fatty acids in altered thyroid states.
Heimberg M; Olubadewo JO; Wilcox HG
Endocr Rev; 1985; 6(4):590-607. PubMed ID: 3908084
[TBL] [Abstract][Full Text] [Related]
11. Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes.
Diekman MJ; Anghelescu N; Endert E; Bakker O; Wiersinga WM
J Clin Endocrinol Metab; 2000 May; 85(5):1857-62. PubMed ID: 10843165
[TBL] [Abstract][Full Text] [Related]
12. Thyroxine inversely regulates serum intermediate density lipoprotein levels in children with congenital hypothyroidism.
Asami T; Ciomartan T; Uchiyama M
Pediatr Int; 1999 Jun; 41(3):266-9. PubMed ID: 10365575
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for cardiovascular disease in women with subclinical hypothyroidism.
Luboshitzky R; Aviv A; Herer P; Lavie L
Thyroid; 2002 May; 12(5):421-5. PubMed ID: 12097204
[TBL] [Abstract][Full Text] [Related]
14. Thyroid hormone action on intermediary metabolism. Part II: Lipid metabolism in hypo- and hyperthyroidism.
Müller MJ; Seitz HJ
Klin Wochenschr; 1984 Jan; 62(2):49-55. PubMed ID: 6708390
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein (a) levels in thyroid dysfunction before and after treatment.
Sucić M; Bozikov V; Mesić R; Sokolić L
Croat Med J; 1998 Mar; 39(1):19-22. PubMed ID: 9475802
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Thyroid Dysfunction and Serum Lipids: A Systematic Review and Meta-analysis.
Kotwal A; Cortes T; Genere N; Hamidi O; Jasim S; Newman CB; Prokop LJ; Murad MH; Alahdab F
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32954428
[TBL] [Abstract][Full Text] [Related]
17. [Thyroid hormones and the metabolism of lipoproteins].
Berthezene F; Perrot L; De Parscau L; Valentin C; Richard L
Ann Endocrinol (Paris); 1983; 44(1):73-6. PubMed ID: 6347029
[TBL] [Abstract][Full Text] [Related]
18. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
[TBL] [Abstract][Full Text] [Related]
19. Long-term thyroid replacement therapy and levels of lipoprotein(a) and other lipoproteins.
Pazos F; Alvarez JJ; Rubiés-Prat J; Varela C; Lasunción MA
J Clin Endocrinol Metab; 1995 Feb; 80(2):562-6. PubMed ID: 7852521
[TBL] [Abstract][Full Text] [Related]
20. Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency.
Ikewaki K; Nishiwaki M; Sakamoto T; Ishikawa T; Fairwell T; Zech LA; Nagano M; Nakamura H; Brewer HB; Rader DJ
J Clin Invest; 1995 Sep; 96(3):1573-81. PubMed ID: 7657828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]